: Determining where the therapeutic gene goes in the body and how long it persists in both target and non-target cells.
This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects. 125459
Guideline on the Non-Clinical Studies Required before First ... - EMA : Determining where the therapeutic gene goes in